Emergent BioSolutions (EBS) Cash from Operations (2010 - 2026)
Emergent BioSolutions (EBS) posted Cash from Operations of $56.1 million for Q2 2026, up 265.98% on a QoQ basis from -$33.8 million in Q1 2026, and down 47.27% year-over-year from $106.4 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Cash from Operations (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Cash from Operations for 17 years, with the latest figure at $56.1 million in Q2 2026.
- On a quarterly basis, Cash from Operations fell 47.27% year-over-year to $56.1 million in Q2 2026; TTM through Jun 2026 was $97.7 million, a 42.19% decrease from a year earlier, with the FY2025 full-year figure at $170.6 million, up 190.63% from the prior year.
- Cash from Operations was $56.1 million for Q2 2026 at Emergent BioSolutions, up from -$33.8 million in the prior quarter.
- The five-year high for Cash from Operations was $153.7 million in Q3 2024, with the low at -$184.0 million in Q1 2023.
- Average Cash from Operations over 5 years is $622222.2, with a median of -$6.8 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations slumped 831.37% in 2022, then jumped 197.25% in 2025.
- Over 5 years, Cash from Operations stood at $92.8 million in 2022, then tumbled by 65.41% to $32.1 million in 2023, then sank by 348.91% to -$79.9 million in 2024, then surged by 197.25% to $77.7 million in 2025, then decreased by 27.8% to $56.1 million in 2026.
- The last three Cash from Operations figures came in at $56.1 million (Q2 2026), -$33.8 million (Q1 2026), and $77.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 835.00 Mn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 3.39 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 3.44 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 462.82 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | -387.32 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 56.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.10 Mn |
| Mar 31, 2026 | -33.80 Mn |
| Dec 31, 2025 | 77.70 Mn |
| Sep 30, 2025 | -2.30 Mn |
| Jun 30, 2025 | 106.40 Mn |
| Mar 31, 2025 | -11.20 Mn |
| Dec 31, 2024 | -79.90 Mn |
| Sep 30, 2024 | 153.70 Mn |
| Jun 30, 2024 | 47.50 Mn |
| Mar 31, 2024 | -62.60 Mn |
| Dec 31, 2023 | 32.10 Mn |
| Sep 30, 2023 | 60.00 Mn |
| Jun 30, 2023 | -114.40 Mn |
| Mar 31, 2023 | -184.00 Mn |
| Dec 31, 2022 | 92.80 Mn |
| Sep 30, 2022 | -74.00 Mn |
| Jun 30, 2022 | -15.60 Mn |
| Mar 31, 2022 | -37.30 Mn |
| Dec 31, 2021 | 328.10 Mn |
| Sep 30, 2021 | 16.70 Mn |
API Access
Emergent BioSolutions Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();